Invention Grant
- Patent Title: TRAF 6 inhibitors
-
Application No.: US16812691Application Date: 2020-03-09
-
Publication No.: US11001591B2Publication Date: 2021-05-11
- Inventor: Kamyar Hadian , Jara Kerstin Brenke , Oliver Plettenburg , Gerrit Juerjens
- Applicant: HELMHOLTZ ZENTRUM MUENCHEN—DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH)
- Applicant Address: DE Neuherberg
- Assignee: HELMHOLTZ ZENTRUM MUENCHEN—DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH)
- Current Assignee: HELMHOLTZ ZENTRUM MUENCHEN—DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH)
- Current Assignee Address: DE Neuherberg
- Agency: Westerman, Hattori, Daniels & Adrian, LLP
- Priority: EP16189150 20160916
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61P25/16 ; A61P17/06 ; A61P9/00 ; A61P35/00 ; A61P37/00 ; A61P3/10 ; A61K31/5025
Abstract:
The invention relates to compounds which are suitable for the treatment of cancer, an immune disease, Parkinson's disease, Cardiac Hypertrophy or Type-2 diabetes and to pharmaceutical compositions containing such compounds. The invention further relates to a kit of parts comprising such compounds.
Public/Granted literature
- US20200277297A1 TRAF 6 INHIBITORS Public/Granted day:2020-09-03
Information query
